All terms in CHEBI
| Label | Id | Description |
|---|---|---|
| mammalian metabolite | CHEBI_75768 | [Any animal metabolite produced during a metabolic reaction in mammals.] |
| ornidazole | CHEBI_75176 | [A C-nitro compound that is 5-nitroimidazole in which the hydrogens at positions 1 and 2 are replaced by 3-chloro-2-hydroxypropyl and methyl groups, respectively. It is used in the treatment of susceptible protozoal infections and for the treatment of anaerobic bacterial infections.] |
| antitrichomonal drug | CHEBI_50685 | [A drug used to treat trichomonas infections.] |
| CHEBI_75177 | CHEBI_75177 | |
| urea hydrogen peroxide | CHEBI_75178 | [A mixture obtained by combining equimolar amounts of hydrogen peroxide and urea.] |
| mixture | CHEBI_60004 | [A mixture is a chemical substance composed of multiple molecules, at least two of which are of a different kind.] |
| urea | CHEBI_16199 | [A carbonyl group with two C-bound amine groups.] |
| hydrogen peroxide | CHEBI_16240 | [An inorganic peroxide consisting of two hydroxy groups joined by a covalent oxygen-oxygen single bond.] |
| reagent | CHEBI_33893 | [A substance used in a chemical reaction to detect, measure, examine, or produce other substances.] |
| trifluridine | CHEBI_75179 | [A pyrimidine 2'-deoxyribonucleoside compound having 5-trifluoromethyluracil as the nucleobase. An antiviral drug used mainly in the treatment of primary keratoconjunctivitis and recurrent epithelial keratitis.] |
| nucleoside analogue | CHEBI_60783 | [An analogue of a nucleoside, being an N-glycosyl compound in which the nitrogen-containing moiety is a modified nucleotide base. They are commonly used as antiviral products to prevent viral replication in infected cells.] |
| EC 2.1.1.45 (thymidylate synthase) inhibitor | CHEBI_63720 | [An EC 2.1.1.* (methyltransferases) inhibitor that interferes with the action of thymidylate synthase (EC 2.1.1.45).] |
| zaragozic acid A | CHEBI_75170 | [A polyketide isolated from fungi that is a potent inhibitor of fungal and mammalian squalene synthase.] |
| oxabicycloalkane | CHEBI_46733 | |
| CHEBI_75171 | CHEBI_75171 | |
| formestane | CHEBI_75172 | [A 17-oxo steroid that is androst-4-ene-3,17-dione in which the hydrogen at position 4 is replaced by a hydroxy group. Formestane was the first selective, type I steroidal aromatase inhibitor, suppressing oestrogen production from anabolic steroids or prohormones. It was formerly used in the treatment of oestrogen-receptor positive breast cancer in post-meopausal women. As it has poor oral bioavailability, it had to be administered by (fortnightly) intramuscular injection. It fell out of use with the subsequent development of cheaper, orally active aromatase inhibitors. Formestane is listed by the World Anti-Doping Agency as a substance prohibited from use by athletes.] |
| androstane | CHEBI_35509 | |
| 1-acyl-2-oleoyl-sn-glycero-3-phospho-(1'-sn-glycerol)(1-) | CHEBI_75173 | [A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol)(1-) in which the acyl group at position 1 is unspecified while that at position 2 is specified as oleoyl] |
| alpha-D-mannosyl group | CHEBI_75185 | [A mannosyl group derived from alpha-D-mannose.] |
| mannosyl group | CHEBI_25170 | [The simplest member of the class of mannosyl groups obtained by removing the hydroxy group from the hemiacetal function of a mannose.] |